C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
11/2001
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/21/2001	CN1075078C Producing process of stem cell factor
11/20/2001	US6320103 Transgenic plants with intensified osmotolerance
11/20/2001	US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics
11/20/2001	US6320036 GbpA
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319706 Device for use in the bioremediation of polluted soils
11/20/2001	US6319702 Nucleotide sequencs coding an enzymatic polypeptide and cell targeting compound; for use in treatment of cancer
11/20/2001	US6319699 Bacterial strains and use thereof in fermentation processes for 2-keto-l-gulonic acid protection
11/20/2001	US6319698 Method for producing arachidonic acid
11/20/2001	US6319696 Process for producing L-amino acids
11/20/2001	US6319690 Preparation and use of gene banks of human antibodies (“human-antibody libraries”)
11/20/2001	US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319685 Polypeptide for generation of amidated agricultral and medical products
11/20/2001	US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence
11/20/2001	US6319382 Adding whey protein substrate for lactic acid-forming bacteria; hydrolyzing to amino acids with enzyme; ultrafiltration
11/20/2001	CA2163015C 5' nucleases derived from thermostable dna polymerase
11/20/2001	CA2084521C Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method
11/20/2001	CA2077691C Oxidation resistant thrombomodulin analogs
11/20/2001	CA2053864C Modified forms of reproductive hormones
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/15/2001	WO2001085975A1 Process for the preparation of dihydroxy esters and derivatives thereof
11/15/2001	WO2001085973A1 Antisense type gene trap vector
11/15/2001	WO2001085960A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	WO2001085905A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
11/15/2001	WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001	WO2001085770A2 Sentinel virus ii
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	WO2001019974A3 Recombinant microorganisms
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001	WO2000031245A8 Creatine amidinohydrolase and process for producing the same
11/15/2001	US20010041358 Method of producing a polyunsaturated fatty acid containing culture and polyunsaturated fatty acid containing oil using microorganisms
11/15/2001	DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway
11/15/2001	DE10021731A1 Cyclipostine, Verfahren zu ihrer Herstellung und Verwendung derselben Cyclipostins, processes for their preparation and use thereof
11/15/2001	CA2677945A1 Process for the preparation of dihydroxy esters and derivatives thereof
11/15/2001	CA2409679A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	CA2408738A1 Virulence genes, proteins, and their use
11/15/2001	CA2406644A1 Sentinel virus ii
11/15/2001	CA2379095A1 Antisense gene-trap vector
11/14/2001	EP1154021A2 Polyhidroxyalkanoate synthase and gene encoding the same enzyme
11/14/2001	EP1153124A2 Methods to mediate polyketide synthase module effectiveness
11/14/2001	EP1153123A2 Pluripotential cells-2
11/14/2001	EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001	EP1153120A1 Method for producing l-sorbose
11/14/2001	EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
11/14/2001	EP1152767A2 Method for producing anti-tumor th1 cells
11/14/2001	EP1012254A4 Method for reducting bioavailability of lead by a lead-sequestering soil bacterium
11/14/2001	EP0763117B1 Synthetic leader peptide sequences
11/14/2001	EP0715653B1 Humanised antibodies
11/14/2001	EP0546110B1 New insulin-like growth factor binding protein igfbp-5
11/14/2001	EP0546074B1 Genetic material encoding igfbp-5
11/14/2001	CN1322248A Plant disease resistance signalling gene, mateirals and methods relating thereto
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1321772A Direct saccharifying of cassave and amino acid fermentation using saccharide solution
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321695A Poly(hydroxy alkanoate), its preparation method and use of microbe in its preparation
11/13/2001	US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/13/2001	US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001	US6316601 Antibodies specific for β6 integrins
11/13/2001	US6316597 Protein for use in treatment of bone or cartilage defects
11/13/2001	US6316488 Antibiotic compound
11/13/2001	US6316262 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
11/13/2001	US6316244 E. coli, Salmonella or Hafnia autoinducers
11/13/2001	US6316242 Method for producing nitrile hydratase
11/13/2001	US6316238 Process for producing activated human ALT
11/13/2001	US6316233 Generating preferentially halogenated compounds using pseudomonas; culture cells, mix with halogenated substrate, isolated preferentially halogenated compounds
11/13/2001	US6316232 Microbial preparation of substances from aromatic metabolism/I
11/13/2001	US6316231 For fermentative conversion of l-sorbose;
11/13/2001	US6316226 For use in treatment of hemophilia a
11/13/2001	US6316220 Found in aspergillii
11/13/2001	US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same
11/13/2001	US6316216 Mutated prenyl diphosphate synthases
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/08/2001	WO2001083807A1 Resolution of aminotetralins
11/08/2001	WO2001083803A1 Overproduction hosts for biosynthesis of polyketides
11/08/2001	WO2001083800A2 Heterologous production of polyketides
11/08/2001	WO2001083799A1 Process for the preparation of alkaline earth salts of d-pantothenic acid
11/08/2001	WO2001083786A2 Stable zymomonas mobilis xylose and arabinose fermenting strains
11/08/2001	WO2001083785A2 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	WO2001083774A2 Novel mutated form of arginine deiminase
11/08/2001	WO2001083704A1 Spray-dried microbial cells
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083497A1 Cyclipostins, a method for their production and the use of the same
11/08/2001	WO2001083437A1 Process for extracting astaxanthin pigment from yeast and extracted pigment thereof
11/08/2001	WO2001034780A3 Cytochrome p450 oxygenases and their uses
11/08/2001	WO2001026680A3 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells
11/08/2001	WO2001009352A3 Use of aspergillus sojae as host for recombinant protein production
11/08/2001	WO2000006713A8 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
11/08/2001	US20010039046 Genetically engineered adenovirus comprising a genome whose E1 region is deactivated, whose organization is modified and the recombination of which with the genome of the producing line leads to the new viral vectors; gene therapy
11/08/2001	US20010039024 Process for identifying and enriching cell-specific target structures
11/08/2001	US20010039023 Process for identifying cell-specific target structures
11/08/2001	US20010039021 Polyketides
11/08/2001	DE10021515A1 Verfahren zur Herstellung von Erdalkalisalzen der D-Pantothensäure A process for preparing alkaline earth salts of D-pantothenic acid
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407808A1 Cyclipostins, process for their preparation and use thereof
11/08/2001	CA2407776A1 Resolution of aminotetralins

1 ... 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 ... 921